Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).
Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2021).
Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586–1600 (2022).
Sparmann, A. & Vogel, J. RNA-based medicine: from molecular mechanisms to therapy. EMBO J. 42, e114760 (2023).
Liu, C. et al. mRNA-based cancer therapeutics. Nat. Rev. Cancer 23, 526–543 (2023).
Wesselhoeft, R. A. et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol. Cell 74, 508–520 (2019).
Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).
Meganck, R. M. et al. Tissue-dependent expression and translation of circular RNAs with recombinant AAV vectors in vivo. Mol. Ther. Nucleic Acids 13, 89–98 (2018).
Meganck, R. M. et al. Engineering highly efficient backsplicing and translation of synthetic circRNAs. Mol. Ther. Nucleic Acids 23, 821–834 (2021).
Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185, 1728–1744 (2022).
Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262–272 (2023).
Unti, M. J. & Jaffrey, S. R. Highly efficient cellular expression of circular mRNA enables prolonged protein expression. Cell Chem. Biol. 31, 163–176 (2024).
Amaya, L. et al. Circular RNA vaccine induces potent T cell responses. Proc. Natl Acad. Sci. USA 120, e2302191120 (2023).
Pelletier, J., Schmeing, T. M. & Sonenberg, N. The multifaceted eukaryotic cap structure. Wiley Interdiscip. Rev. RNA 12, e1636 (2021).
Pelletier, J. & Sonenberg, N. The organizing principles of eukaryotic ribosome recruitment. Annu. Rev. Biochem. 88, 307–335 (2019).
Wang, Y. & Wang, Z. F. Efficient backsplicing produces translatable circular mRNAs. RNA 21, 172–179 (2015).
Yang, Y. et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 27, 626–641 (2017).
He, P. C. & He, C. m6A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 40, e105977 (2021).
Hellen, C. U. T. IRES-induced conformational changes in the ribosome and the mechanism of translation initiation by internal ribosomal entry. Biochim. Biophys. Acta 1789, 558–570 (2009).
Hall, M. P. et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem. Biol. 7, 1848–1857 (2012).
Abe, N. et al. Complete chemical synthesis of minimal messenger RNA by efficient chemical capping reaction. ACS Chem. Biol. 17, 1308–1314 (2022).
Ellipilli, S., Phillips, J. D. & Heemstra, J. M. Synthesis of comb-shaped DNA using a non-nucleosidic branching phosphoramidite. Org. Biomol. Chem. 16, 4659–4664 (2018).
Abe, N. et al. Rolling circle translation of circular RNA in living human cells. Sci. Rep. 5, 16435 (2015).
Karikó, K., Buckstein, M., Ni, H. P. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).
Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008).
Kao, C., Zheng, M. & Rüdisser, S. A simple and efficient method to reduce nontemplated nucleotide addition at the 3′ terminus of RNAs transcribed by T7 RNA polymerase. RNA 5, 1268–1272 (1999).
Santoro, S. W. & Joyce, G. F. A general purpose RNA-cleaving DNA enzyme. Proc. Natl Acad. Sci. USA 94, 4262–4266 (1997).
Gamper, H. et al. Synthesis of long RNA with a site-specific modification by enzymatic splint ligation. Preprint at bioRxiv https://doi.org/10.1101/2022.09.17.508400 (2022).
Palmenberg, A. C., Rathe, J. A. & Liggett, S. B. Analysis of the complete genome sequences of human rhinovirus. J. Allergy Clin. Immunol. 125, 1190–1199 (2010).
Bordeleau, M. E. et al. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat. Chem. Biol. 2, 213–220 (2006).
Steinberger, J. et al. Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5′ leader regions. Nucleic Acids Res. 48, 9521–9537 (2020).
Abdullah, S. W., Wu, J. E., Wang, X. F., Guo, H. C. & Sun, S. Q. Advances and breakthroughs in IRES-directed translation and replication of picornaviruses. mBio 14, e0035823 (2023).
Bernstein, P., Peltz, S. W. & Ross, J. The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol. Cell. Biol. 9, 659–670 (1989).
Deo, R. C., Bonanno, J. B., Sonenberg, N. & Burley, S. K. Recognition of polyadenylate RNA by the poly(A)-binding protein. Cell 98, 835–845 (1999).
Henderson, J. M. et al. Cap 1 messenger RNA synthesis with co-transcriptional CleanCap(®) analog by in vitro transcription. Curr. Protoc. 1, e39 (2021).
Zeng, C., Zhang, C., Walker, P. G. & Dong, Y. Formulation and delivery technologies for mRNA vaccines. Curr. Top. Microbiol. Immunol. 440, 71–110 (2022).
Husseini, R. A., Abe, N., Hara, T., Abe, H. & Kogure, K. Use of iontophoresis technology for transdermal delivery of a minimal mRNA vaccine as a potential melanoma therapeutic. Biol. Pharm. Bull. 46, 301–308 (2023).
Imani, S., Tagit, O. & Pichon, C. Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact. NPJ Vaccines 9, 14 (2024).
Puttaraju, M. et al. Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome. Nat. Med. 27, 526–535 (2021).
Lu, Z. J. & Mathews, D. H. Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design. Nucleic Acids Res. 36, 3738–3745 (2008).
Egli, M. & Manoharan, M. Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Res. 51, 2529–2573 (2023).
Lesiak, K., Khamnei, S. & Torrence, P. F. 2′,5′-Oligoadenylate:antisense chimeras. Synthesis and properties. Bioconjugate Chem. 4, 467–472 (1993).
Passmore, L. A. & Coller, J. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression. Nat. Rev. Mol. Cell Biol. 23, 93–106 (2022).
Picard-Jean, F. et al. 2′-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO. PLoS ONE 13, e0193804 (2018).
Despic, V. & Jaffrey, S. R. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature 614, 358–366 (2023).
Koshkin, A. A. et al. LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron 54, 3607–3630 (1998).
Obika, S. et al. Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides. Tetrahedron Lett. 39, 5401–5404 (1998).
Costello, A., Lao, N. T., Barron, N. & Clynes, M. Continuous translation of circularized mRNA improves recombinant protein titer. Metab. Eng. 52, 284–292 (2019).
Mattick, J. S. et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 24, 430–447 (2023).
Yu, X., Zheng, H. Y., Chan, M. T. V. & Wu, W. K. K. HULC: an oncogenic long non-coding RNA in human cancer. J. Cell. Mol. Med. 21, 410–417 (2017).
Zhao, Y. et al. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol. Rep. 31, 358–364 (2014).
Joseph, R., Srivastava, O. P. & Pfister, R. R. Downregulation of β-actin and its regulatory gene HuR affect cell migration of human corneal fibroblasts. Mol. Vis. 20, 593–605 (2014).
Morais, P., Adachi, H. & Yu, Y. T. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front. Cell Dev. Biol. 9, 789427 (2021).
Bathula, N. V. et al. Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity. J. Control. Release 374, 28–38 (2024).
Anderluzzi, G. et al. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. J. Control. Release 342, 388–399 (2022).
Münter, R., Christensen, E., Andresen, T. L. & Larsen, J. B. Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution. Mol. Ther. Methods Clin. Dev. 29, 450–459 (2023).
Darrah, P. A. et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature 577, 95–102 (2020).
Leppek, K., Das, R. & Barna, M. Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat. Rev. Mol. Cell Biol. 19, 158–174 (2018).
Paek, K. Y., Park, S. M., Hong, K. Y. & Jang, S. K. Cap-dependent translation without base-by-base scanning of an messenger ribonucleic acid. Nucleic Acids Res. 40, 7541–7551 (2012).
Carrieri, C. et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 491, 454–457 (2012).
Pierattini, B. et al. SINEUP non-coding RNA activity depends on specific N6-methyladenosine nucleotides. Mol. Ther. Nucleic Acids 32, 402–414 (2023).
Sharma, H. et al. Decryption of sequence, structure, and functional features of SINE repeat elements in SINEUP non-coding RNA-mediated post-transcriptional gene regulation. Nat. Commun. 15, 1400 (2024).
Cao, Y. et al. RNA-based translation activators for targeted gene upregulation. Nat. Commun. 14, 6827 (2023).
Cao, X. A., Zhang, Y. Y., Ding, Y. L. & Wan, Y. Identification of RNA structures and their roles in RNA functions. Nat. Rev. Mol. Cell Biol. 25, 784–801 (2024).
Sun, L. et al. RNA structure maps across mammalian cellular compartments. Nat. Struct. Biol. 26, 322–330 (2019).
Liu, C. X. & Chen, L. L. Circular RNAs: characterization, cellular roles, and applications. Cell 185, 2016–2034 (2022).
Diallo, L. H. et al. How are circRNAs translated by non-canonical initiation mechanisms? Biochimie 164, 45–52 (2019).
Legnini, I. et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol. Cell 66, 22–37 (2017).
Pitsch, S., Weiss, P. A., Jenny, L., Stutz, A. & Wu, X. L. Reliable chemical synthesis of oligoribonucleotides (RNA) with 2′-O-[(triisopropylsilyl)oxy]methyl(2′-O-tom)-protected phosphoramidites. Helv. Chim. Acta 84, 3773–3795 (2001).
Ototake, M. et al. Development of hydrophobic tag purifying monophosphorylated RNA for chemical synthesis of capped mRNA and enzymatic synthesis of circular mRNA. Nucleic Acids Res. 52, 12141–12157 (2024).
Inagaki, M. et al. Cap analogs with a hydrophobic photocleavable tag enable facile purification of fully capped mRNA with various cap structures. Nat. Commun. 14, 2657 (2023).
